Literature DB >> 4622449

C3 inactivating factor in the serum of a patient with chronic hypocomplementaemic proliferative glomerulo-nephritis.

R A Thompson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4622449      PMCID： PMC1408205     

Source DB:  PubMed          Journal:  Immunology        ISSN： 0019-2805            Impact factor:   7.397


× No keyword cloud information.
  11 in total

1.  [Method permitting the combined study of the electrophoretic and the immunochemical properties of protein mixtures; application to blood serum].

Authors:  P GRABAR; C A WILLIAMS
Journal:  Biochim Biophys Acta       Date:  1953-01

2.  Biologically active water-insoluble protein polymers. I. Their use for isolation of antigens and antibodies.

Authors:  S Avrameas; T Ternynck
Journal:  J Biol Chem       Date:  1967-04-10       Impact factor: 5.157

3.  The complement profile in acute glomerulonephritis systemic lupus erythematosus and hypocomplementemic chronic glomerulonephritis. Contrasts and experimental correlations.

Authors:  H Gewurz; R J Pickering; S E Mergenhagen; R A Good
Journal:  Int Arch Allergy Appl Immunol       Date:  1968

4.  Chronic glomerulonephritis associated with low serum complement activity (chronic hypocomplementemic glomerulonephritis).

Authors:  R J Pickering; R C Herdman; A F Michael; R L Vernier; H Gewurz; A J Fish; R A Good
Journal:  Medicine (Baltimore)       Date:  1970-05       Impact factor: 1.889

5.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

6.  Serial complement component alterations in acute glomerulonephritis and systemic lupus erythematosus.

Authors:  P F Kohler; R Ten Bensel
Journal:  Clin Exp Immunol       Date:  1969-02       Impact factor: 4.330

7.  Complement inactivation by serum from patients with acute and hypocomplementemic chronic glomerulonephritis.

Authors:  R J Pickering; H Gewurz; R A Good
Journal:  J Lab Clin Med       Date:  1968-08

8.  Immune haemolysis in agar: demonstration of the protective action of antibodies.

Authors:  R A Thompson; D S Rowe
Journal:  Immunology       Date:  1967-10       Impact factor: 7.397

9.  Reactive lysis: the complement-mediated lysis of unsensitized cells. I. The characterization of the indicator factor and its identification as C7.

Authors:  R A Thompson; P J Lachmann
Journal:  J Exp Med       Date:  1970-04-01       Impact factor: 14.307

10.  Characteristics of a non-complement-dependent C3-reactive complex formed form factors in nephritic and normal serum.

Authors:  E H Vallota; J Forristal; R E Spitzer; N C Davis; C D West
Journal:  J Exp Med       Date:  1970-06-01       Impact factor: 14.307
View more
  29 in total

1.  Identification of nephritic factor as an immunoglobulin.

Authors:  D G Williams; A Bartlett; P Duffus
Journal:  Clin Exp Immunol       Date:  1978-09       Impact factor: 4.330

2.  Requirements for the production of high-titre C3 nephritic factor (NEF) antibody in vitro.

Authors:  M A Marín; G Fontán; M López-Trascasa
Journal:  Immunology       Date:  1992-06       Impact factor: 7.397

3.  Episcleritis and scleritis. A study of their clinical manifestations and association with rheumatoid arthritis.

Authors:  D D McGavin; J Williamson; J V Forrester; W S Foulds; W W Buchanan; W C Dick; P Lee; R N MacSween; K Whaley
Journal:  Br J Ophthalmol       Date:  1976-03       Impact factor: 4.638

4.  Studies of the action of some anti-inflammatory drugs on complement mediated immune haemolysis.

Authors:  K Whaley; D J Sloane
Journal:  Br J Clin Pharmacol       Date:  1975-04       Impact factor: 4.335

5.  The immunogloblin nature of nephritic factor (NeF).

Authors:  D M Scott; N Amos; J G Sissons; P J Lachmann; D K Peters
Journal:  Clin Exp Immunol       Date:  1978-04       Impact factor: 4.330

6.  Heterogeneity of nephritic factor and its identification as an immunoglobulin.

Authors:  A E Davis; J B Ziegler; E W Gelfand; F S Rosen; C A Alper
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

7.  Effect of nephritic factor on C3 and on the terminal pathway of complement in vivo and in vitro.

Authors:  T E Mollnes; Y C Ng; D K Peters; T Lea; J Tschopp; M Harboe
Journal:  Clin Exp Immunol       Date:  1986-07       Impact factor: 4.330

8.  Immune reactants in cryoproteins. Relationship to complement activation.

Authors:  M R Wilson; C M Arroyave; L Miles; E M Tan
Journal:  Ann Rheum Dis       Date:  1977-12       Impact factor: 19.103

9.  Metabolic studies of the third component of complement and the glycine-rich beta glycoprotein in patients with hypocomplementemia.

Authors:  J A Charlesworth; D G Williams; E Sherington; P J Lachmann; D K Peters
Journal:  J Clin Invest       Date:  1974-06       Impact factor: 14.808

10.  C3 nephritic factor and hypocomplementaemia in a clinically healthy individual.

Authors:  A T Gewurz; S M Imherr; S Strauss; H Gewurz; C Mold
Journal:  Clin Exp Immunol       Date:  1983-10       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.